In recent years,the
incidence and
mortality of advanced
lung cancer in
elderly patients have been increasing,but the number of
elderly patients with
lung cancer who receive active
treatment is less than that of
lung caner
patients in other age stage.
Molecular targeted therapies,such as the
human epidermal growth factor receptor tyrosine kinase inhibitors,
angiogenesis inhibitors,anti-
tumor monoclonal antibodies and multitarget
drugs,have prolonged the overall
survival and improved the
life quality of
elderly patients with advanced
non-small cell lung cancer.Targeted
therapy has become the most promising
treatment and can significantly improve the
prognosis of
elderly patients.